Back to today’s briefing

Story perspectives

Six-Month-Old KJ Muldoon: A CRISPR Hope for Rare Disorders

5/28/2025

28 3

Summary

Story summary

KJ Muldoon, just six months old, has become a beacon of hope after receiving a pioneering CRISPR gene-editing treatment for his severe condition. This remarkable step in personalized medicine not only offers potential breakthroughs for rare genetic disorders but also sparks vital discussions about the future of accessibility and scalability in such innovative therapies. All eyes are on KJ as his journey unfolds.

1 of 1

Story summary

KJ Muldoon, just six months old, has become a beacon of hope after receiving a pioneering CRISPR gene-editing treatment for his severe condition. This remarkable step in personalized medicine not only offers potential breakthroughs for rare genetic disorders but also sparks vital discussions about the future of accessibility and scalability in such innovative therapies. All eyes are on KJ as his journey unfolds.